Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Emily Rapalino
ID:
1b83d0ce-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
14 articles
Amgen Launches Its Aflibercept Biosimilar In the U.S.
Big Molecule Watch ·
November 5, 2024
cite
FDA Approves Moderna’s and Pfizer/BioNTech’s Updated COVID-19 Vaccines
Big Molecule Watch ·
September 3, 2024
cite
Genentech, Roche, and Biogen Sue Dr. Reddy’s and Fresenius for a Proposed Biosimilar of Rituxan in District of New Jersey
Big Molecule Watch ·
November 21, 2023
cite
Regeneron Moves to Terminate Celltrion IPR on Aflibercept Patent After Regeneron Files Statutory Disclaimer
Big Molecule Watch ·
August 14, 2023
cite
Delaware District Court Adopts Magistrate Judge’s Report and Recommendation Denying Amgen’s Motion to Dismiss Regeneron’s Antitrust Claims, Overruling Amgen’s Objections
Big Molecule Watch ·
March 23, 2023
cite
Previous
1
2
3
Next
